Gut-microbiota-intestinal barrier axis

The gut-microbiota-intestinal barrier axis is a complex physiological system comprising the trillions of microorganisms in the digestive tract, the physical epithelial lining, and the biochemical signals they exchange. This axis is critical for maintaining systemic health by facilitating nutrient absorption while preventing the translocation of harmful bacterial toxins, such as lipopolysaccharides (LPS), into the bloodstream (Ghosh et al., 2020, American Journal of Physiology-Renal Physiology). The integrity of the intestinal barrier is maintained by tight junction proteins, including claudins and occludins, which are regulated by both host signals and microbial metabolites like short-chain fatty acids (Vancamelbeke & Vermeire, 2017, Expert Review of Gastroenterology & Hepatology). When this barrier is compromised—a state often referred to as "leaky gut"—endotoxins can enter the systemic circulation, triggering Toll-like receptor 4 (TLR4) and driving chronic inflammation (Fasano, 2020, F1000Research). This process is a key driver in the pathogenesis of diverse conditions, including inflammatory bowel disease (IBD), metabolic syndrome, nonalcoholic fatty liver disease (NAFLD), and certain autoimmune disorders. Current therapeutic strategies focus on modulating the microbiota through probiotics or non-absorbable antibiotics and developing agents that directly reinforce the epithelial barrier or neutralize circulating toxins.

Other names

Intestinal mucosal barrierGut-microbiome axisLeaky gutIntestinal permeabilityGut microbiota / intestinal barrier / bacterial toxins

Therapeutic interventions target this axis through several mechanisms: antibiotics like rifaximin reduce the population of toxin-producing bacteria; probiotics and prebiotics modulate the microbiome to favor species that produce barrier-strengthening metabolites; and tight junction regulators like larazotide inhibit zonulin signaling to reduce paracellular permeability (Fasano, 2020; Vancamelbeke & Vermeire, 2017).